SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Fancy who wrote (4718)7/3/1998 2:14:00 AM
From: Stewart Whitman  Read Replies (1) of 6136
 
Steve,

If you look at AGPH's cash flow statement, you'll see they brought in about $38 million last quarter. Net income was quite deceptive at $13 million. If this cash flow continues for a few more quarters, AGPH should be able to pay for the deals made in the last few weeks relatively easily. Even at lower revenue levels (e.g. previous quarters, AGPH generated substantial positive cash flow).

Stew
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News